Cytokines as mediators of graft-versus-host disease
- PMID: 3048486
Cytokines as mediators of graft-versus-host disease
Abstract
Cytokines are proteins produced mainly by lymphocytes in response to an antigenic stimulus. Originally identified and named on the basis of their biological activity, they are now called interleukins; together with the interferons, colony-stimulating factors and tumour necrosis factor/cachectin (TNF) they form a complex and overlapping network of communication between immunocompetent cells. Cytokines play a central role in T cell activation, and interleukin 2 and interferon gamma in particular are involved in the expression of graft-versus-host disease after bone marrow transplantation. Recent studies suggest that TNF is also implicated: the gene encoding TNF is situated close to the MHC gene in both mice and humans, and TNF is able to up-regulate constitutively expressed class II antigen and, with interferon gamma, to induce class II expression in previously normal cells. Bacterial lipopolysaccharide (endotoxin) is a powerful stimulus to TNF, and TNF production may be the mechanism underlying the longstanding observations on the role of the bacterial microflora of the gut in graft-versus-host disease.
Similar articles
-
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.Biol Blood Marrow Transplant. 2004 Mar;10(3):156-70. doi: 10.1016/j.bbmt.2003.10.005. Biol Blood Marrow Transplant. 2004. PMID: 14993881
-
Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.Bone Marrow Transplant. 1994 Jun;13(6):745-51. Bone Marrow Transplant. 1994. PMID: 7920309
-
Cytokines involved in graft-versus-host disease.Hokkaido Igaku Zasshi. 1994 Nov;69(6):1348-53. Hokkaido Igaku Zasshi. 1994. PMID: 7705747 Review.
-
Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.J Immunol. 1995 Jul 15;155(2):585-93. J Immunol. 1995. PMID: 7608537
-
Lymphokines and the acute-phase response in clinical bone marrow transplantation.Eur Cytokine Netw. 1990 Oct-Nov;1(4):251-5. Eur Cytokine Netw. 1990. PMID: 1716489 Review.
Cited by
-
Sequential measurement of the murine acute-phase protein serum amyloid P component (SAP) as an indicator of graft-versus-host disease following allogeneic bone marrow transplantation in mice.Clin Exp Immunol. 1990 Aug;81(2):329-33. doi: 10.1111/j.1365-2249.1990.tb03340.x. Clin Exp Immunol. 1990. PMID: 2201471 Free PMC article.
-
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.EMBO J. 1997 Sep 1;16(17):5386-97. doi: 10.1093/emboj/16.17.5386. EMBO J. 1997. PMID: 9311998 Free PMC article.
-
Tumor necrosis factor: an update on basic research and clinical applications.Klin Wochenschr. 1990 Sep 3;68(17):841-6. doi: 10.1007/BF01662779. Klin Wochenschr. 1990. PMID: 2214607 Review.
-
Antigenaemia during acute graft versus host disease.J Clin Pathol. 1995 Feb;48(2):105-9. doi: 10.1136/jcp.48.2.105. J Clin Pathol. 1995. PMID: 7745106 Free PMC article.
-
Graft versus leukemia.Immunol Res. 1992;11(1):24-33. doi: 10.1007/BF02918605. Immunol Res. 1992. PMID: 1602180 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials